Начало › Рак на яйчниците › Илинойс › Chicago
Клинични проучвания за Рак на яйчниците в Chicago, IL
36 проучвания за Рак на яйчниците търсят участници в обекти в и около Chicago (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- Research Site, Chicago
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Набиране на участнициФаза 2/3
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- Mount Sinai Hospital Medical Center, Chicago
- Northwestern University, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- и още 3
A Study of PHST001 in Advanced Solid Tumors
Набиране на участнициФаза 1
- University of Chicago Medical Center, Chicago
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набиране на участнициФаза 1
- University of Chicago Hospital, Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 2
- University of Illinois Cancer Center, Chicago
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
Набиране на участнициФаза 1
- University of Chicago Medical Center /ID# 278295, Chicago
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Набиране на участнициНаблюдателно проучване
- University of Chicago, Chicago
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Набиране на участнициФаза 2
- Rush Md Anderson Cancer Center /ID# 274926, Chicago
- University of Chicago Medical Center /ID# 274796, Chicago
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Набиране на участнициФаза 1/2
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Набиране на участнициФаза 3
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- The University of Chicago Medicine, Chicago
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Набиране на участнициФаза 1
- Northwestern University Feinberg School of Medicine, Chicago
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Набиране на участнициФаза 3
- The University of Chicago Medicine, Chicago
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Набиране на участнициФаза 2
- University of Chicago, Chicago
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- University of Illinois Cancer Center, Chicago
- University of Chicago Medicine, Chicago
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
Набиране на участнициФаза 2
- University of Chicago, Chicago
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Набиране на участнициФаза 1
- University of Chicago Medical Center, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Набиране на участнициФаза 1/2
- Lurie Children's Hospital-Chicago, Chicago
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Набиране на участници
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- и още 2
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Набиране на участнициФаза 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- и още 1
A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
Набиране на участнициФаза 1
- Rush University Medical Center, Chicago
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
Набиране на участнициФаза 2
- The University of Chicago Medical Center, Chicago
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Набиране на участнициФаза 2
- Northwestern Memorial Hospital, Chicago
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Набиране на участнициФаза 1
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- University of Chicago Medical Center, Chicago
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Набиране на участнициФаза 1/2
- Northwestern University, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Набиране на участнициФаза 1/2
- Northwestern Memorial Hospital, Chicago
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Набиране на участници
- Northwestern University, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Набиране на участнициФаза 1/2
- University of Chicago Medical Center, Chicago
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Набиране на участници
- UChicago Medicine, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- University of Chicago Medical Center, Chicago
Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy
Набиране на участници
- Northwestern Memorial Hospital, Chicago
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Набиране на участнициФаза 1
- The University of Chicago Comprehensive Cancer Center, Chicago
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Набиране на участнициФаза 2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Набиране на участнициНаблюдателно проучване
- Massive Bio SYNERGY-AI site, Chicago
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Набиране на участнициФаза 2
- Northwestern University, Chicago
Проучвания за Рак на яйчниците в други градове
- Houston, TX89 проучвания
- New York City, NY69 проучвания
- Boston, MA61 проучвания
- Los Angeles, CA50 проучвания
- Nashville, TN49 проучвания
- Arlington, VA46 проучвания
- Philadelphia, PA44 проучвания
- Columbus, OH39 проучвания
- St. Louis, MO38 проучвания
- San Antonio, TX31 проучвания
- Cleveland, OH30 проучвания
- Pittsburgh, PA30 проучвания
Други проучвания в Chicago
- Рак на белия дроб с недребноклетъчен тип61 проучвания
- Рак на гърдата59 проучвания
- Рак (всички видове)51 проучвания
- Метастатичен рак45 проучвания
- Рак на простатата45 проучвания
- Рак на белия дроб41 проучвания
- Затлъстяване41 проучвания
- Колоректален рак34 проучвания
- Инсульт34 проучвания
- Сърдечна недостатъчност31 проучвания
- Наднормено тегло29 проучвания
- Плоскоклетъчен карцином на главата и шията26 проучвания
От ClinicalTrials.gov, данни към 6.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.